We are live on ! Find out more
ONC

BeOne Medicines Ltd
ONC

208 hedge funds and large institutions have $8.4B invested in BeOne Medicines Ltd in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 64 increasing their positions, 69 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.25% more ownership

Funds ownership: 3.52% → 3.77% (+0.25%)

7% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 69

5% less funds holding

Funds holding: 219 → 208 (-11)

18% less capital invested

Capital invested by funds: $10.3B → $8.4B (-$1.9B)

27% less funds holding in top 10

Funds holding in top 10: 11 → 8 (-3)

29% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 38

64% less call options, than puts

Call options by funds: $10.8M | Put options by funds: $29.9M

Holders
208
Holders Change
-11
Holders Change %
-5.02%
% of All Funds
3.27%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.13%
New
27
Increased
64
Reduced
69
Closed
38
Calls
$10.8M
Puts
$29.9M
Net Calls
-$19.1M
Net Calls Change
-$38.7M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$163M
2
BlackRock
BlackRock
New York
+$37.5M
3
UBS Group
UBS Group
Switzerland
+$12.4M
4
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
+$12.2M
5
Temasek Holdings
Temasek Holdings
Singapore
+$9.59M

Top Sellers

1
HA
HHLR Advisors
Cayman Islands
-$68M
2
Capital International Investors
Capital International Investors
California
-$62.2M
3
State Street
State Street
Massachusetts
-$59.1M
4
FFM
Fairmount Funds Management
Pennsylvania
-$51.6M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$50M
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$2.08B – – –
Capital International Investors
2
Capital International Investors
California
$1.12B -$62.2M -270,200 -4%
HA
3
HHLR Advisors
Cayman Islands
$923M -$68M -295,353 -5%
Primecap Management
4
Primecap Management
California
$894M -$7.2M -31,275 -0.6%
Baillie Gifford & Co
5
Baillie Gifford & Co
United Kingdom
$585M -$7.84M -34,058 -1%
Temasek Holdings
6
Temasek Holdings
Singapore
$536M +$9.59M +41,649 +1%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$407M -$50M -216,923 -9%
Invesco
8
Invesco
Georgia
$278M -$3.22M -13,970 -0.9%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$265M +$163M +709,017 +91%
CII
10
Capital International Inc
California
$164M -$17.9M -77,606 -8%
BlackRock
11
BlackRock
New York
$155M +$37.5M +162,949 +23%
BC
12
Boxer Capital
California
$89.2M – – –
AG
13
Artal Group
Luxembourg
$73.5M -$20.5M -88,839 -18%
PIF
14
Public Investment Fund
Saudi Arabia
$56.6M – – –
Bank of America
15
Bank of America
North Carolina
$51.9M -$4.57M -19,825 -6%
CGPCS
16
Capital Group Private Client Services
California
$40.6M -$4.29M -18,638 -8%
PBA
17
Paradigm Biocapital Advisors
New York
$38.5M +$7.39M +32,081 +17%
Morgan Stanley
18
Morgan Stanley
New York
$32.3M +$5.86M +25,437 +16%
CIS
19
Capital International Sarl
California
$30.2M +$3.83M +16,630 +11%
MGIM
20
M&G Investment Management
United Kingdom
$25.9M +$1.81M +7,844 +6%
AI
21
Axiom Investors
Connecticut
$23M -$8.4M -36,457 -22%
MICM
22
Matthews International Capital Management
California
$22.8M -$2.12M -9,221 -7%
PAMS
23
Pictet Asset Management (Switzerland)
Switzerland
$22.3M +$2.79M +12,114 +11%
Baird Financial Group
24
Baird Financial Group
Wisconsin
$20.5M +$2.07M +8,982 +8%
Millennium Management
25
Millennium Management
New York
$19.8M +$7.66M +33,253 +43%
1
2 3 4 5

ONC Hedge Fund Activity: Q2 2023 in Review

208 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q2 2023, worth a combined $8.4B — down 18% from $10.3B a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of ONC and 27 opened new positions — a net loss of 11 holders — while 69 trimmed existing stakes and 64 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $163M. The largest seller was HHLR Advisors, cutting an estimated $68M.

  • 208 institutional investors held BeOne Medicines Ltd (ONC) as of Q2 2023, down from 219 in Q1 2023.
  • Funds reported $8.4B of BeOne Medicines Ltd stock for Q2 2023, down 18% quarter-over-quarter.
  • 27 funds opened new BeOne Medicines Ltd positions in Q2 2023 and 38 closed out, a net change of -11 holders.
  • The largest BeOne Medicines Ltd buyer in Q2 2023 was T. Rowe Price Associates, an estimated $163M added.
  • The largest BeOne Medicines Ltd seller in Q2 2023 was HHLR Advisors, an estimated $68M sold.

Based on aggregated 13F filings for Q2 2023.